The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease
Authors
Keywords
-
Journal
Journal of Neuroinflammation
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-26
DOI
10.1186/s12974-019-1682-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
- (2019) Lee‐Way Jin et al. Annals of Clinical and Translational Neurology
- FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
- (2019) Shu Yao et al. Journal of Neuroimmune Pharmacology
- The role of Ca 2+ in cell death caused by oxidative glutamate toxicity and ferroptosis
- (2018) Pamela Maher et al. CELL CALCIUM
- Ca2+-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signaling
- (2018) Zhihua Yu et al. Journal of Neuroinflammation
- Inhibition of the potassium channel K Ca 3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury
- (2017) Roland G.W. Staal et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Downregulation of miR-7116-5p in microglia by MPP+ sensitizes TNF-α production to induce dopaminergic neuron damage
- (2017) Qian He et al. GLIA
- The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice
- (2017) Niharika Amireddy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke
- (2017) Mengni Yi et al. Journal of Neuroinflammation
- Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
- (2017) Cornelius J. H. M. Klemann et al. MOLECULAR NEUROBIOLOGY
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP
- (2017) Stefan Schildknecht et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Behavioral changes over time in post-traumatic stress disorder: Insights from a rat model of single prolonged stress
- (2016) Zhuoyun Wu et al. BEHAVIOURAL PROCESSES
- KCa3.1-a microglial target ready for drug repurposing?
- (2016) Elena Dale et al. GLIA
- GRP78 Interacting Partner Bag5 Responds to ER Stress and Protects Cardiomyocytes From ER Stress-Induced Apoptosis
- (2016) Manish K. Gupta et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Unfolded protein response in brain ischemia: A timely update
- (2016) Wei Yang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- TRPM7 kinase activity regulates murine mast cell degranulation
- (2016) Susanna Zierler et al. JOURNAL OF PHYSIOLOGY-LONDON
- A polarizing question: do M1 and M2 microglia exist?
- (2016) Richard M Ransohoff NATURE NEUROSCIENCE
- Ion Channels in Innate and Adaptive Immunity
- (2015) Stefan Feske et al. Annual Review of Immunology
- Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+
- (2015) Stefan Schildknecht et al. ANTIOXIDANTS & REDOX SIGNALING
- Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury
- (2015) Cheng-Lung Chen et al. ARCHIVES OF TOXICOLOGY
- SOCE in neurons: Signaling or just refilling?
- (2015) Lukasz Majewski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Pain Perception in Acute Model Mice of Parkinson's Disease Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)
- (2015) Jihye Park et al. Molecular Pain
- STIM1, STIM2, and Orai1 regulate store-operated calcium entry and purinergic activation of microglia
- (2014) Marlen Michaelis et al. GLIA
- Genetic comorbidities in Parkinson's disease
- (2013) M. A. Nalls et al. HUMAN MOLECULAR GENETICS
- MALDI Mass Spectrometry Imaging of 1-Methyl-4-phenylpyridinium (MPP+) in Mouse Brain
- (2013) Hanane Kadar et al. NEUROTOXICITY RESEARCH
- Selective Activation of KCa3.1 and CRAC Channels by P2Y2 Receptors Promotes Ca2+ Signaling, Store Refilling and Migration of Rat Microglial Cells
- (2013) Roger Ferreira et al. PLoS One
- Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
- (2012) Nicole Exner et al. EMBO JOURNAL
- Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling
- (2012) Senthil Selvaraj et al. JOURNAL OF CLINICAL INVESTIGATION
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels
- (2012) Kate Lykke Lambertsen et al. PLoS One
- Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapo
- (2011) Kenneth I. Ataga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Neuroglia, der lebende Nervenkitt
- (2011) H. Kettenmann et al. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke
- (2011) Yi-Je Chen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Inhibition of the Ca2+-Dependent K+ Channel, KCNN4/KCa3.1, Improves Tissue Protection and Locomotor Recovery after Spinal Cord Injury
- (2011) D. Bouhy et al. JOURNAL OF NEUROSCIENCE
- Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum
- (2010) G. Xu et al. NEUROSCIENCE
- Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia
- (2009) Kenneth I Ataga et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
- (2008) K. I. Ataga et al. BLOOD
- Dopamine agonists in Parkinson’s disease - focus on non-motor symptoms
- (2008) P. Jenner EUROPEAN JOURNAL OF NEUROLOGY
- Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels
- (2008) S. Guerreiro et al. MOLECULAR PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now